Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06004440 · ClinicalTrials.gov registry record
Real World Registry for Use of the Ion Endoluminal System
A clinical trial of Lung Cancer and Neoplasms, sponsored by Intuitive Surgical.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 16
- Study locations
NCT06004440: Recruiting study of Lung Cancer and Neoplasms, sponsored by Intuitive Surgical.
NCT06004440 is a study of Lung Cancer and Neoplasms that is actively recruiting participants, run by Intuitive Surgical. The registered enrollment target is 3,000 participants, above the 928-participant average among 409 other Lung Cancer trials with a reported enrollment target (223% higher). The trial reports 16 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06004440, a study of Lung Cancer and Neoplasms, is actively recruiting participants, sponsored by Intuitive Surgical.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.
Primary Outcome
Defined as the sum of true positives and true negatives divided by the total number of nodules biopsied. Primary outcome analyses will exclude subjects that are enrolled for localization procedure only.
Conditions Studied
Interventions
- DEVICE Ion Endoluminal System
Study Locations (16)
North Carolina
- Atrium Health of the Carolinas - Charlotte
- Cone Health Moses Cone Memorial Hospital - Greensboro
- FirstHealth Moore Regional Hospital - Pinehurst
Illinois
- Ascension Alexian Brothers - Elk Grove Village
- Blessing Hospital - Quincy
Florida
- Orlando Health Orlando Regional Medical Center - Orlando
Kansas
- Kansas University Medical Center - Kansas City
Louisiana
- Tulane University - New Orleans
Michigan
- Henry Ford Hospital - Detroit
Minnesota
- Mayo Clinic - Rochester
New York
- Mercy Hospital of Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2023-09-21 |
| Est. Completion | 2030-08 |
What NCT06004440 shows while recruiting
NCT06004440 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 928-participant average among 409 other Lung Cancer trials with a reported enrollment target (223% higher).
The record links to 9 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Ion Endoluminal System is the first listed.
NCT06004440 lists 16 locations in 13 states (North Carolina, Illinois, Florida).
Frequently Asked Questions
What is clinical trial NCT06004440 about?
NCT06004440 is a clinical study titled "Real World Registry for Use of the Ion Endoluminal System". The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.
What is the current status of trial NCT06004440?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2023-09-21. Estimated completion is 2030-08.
What conditions does trial NCT06004440 study?
This clinical trial studies the following conditions: Lung Cancer, Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms by Site.
What interventions are being tested in trial NCT06004440?
The interventions under investigation include: Ion Endoluminal System (DEVICE).
Who is sponsoring clinical trial NCT06004440?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06004440 being conducted?
This trial has 16 study locations across Florida, Illinois, Kansas, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06004440's enrollment target sits among peer trials
3,000 20th of 409 higher than 390 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI